Trial Profile
Phase I trial of tezampanel in healthy volunteers.
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 22 May 2015
Price :
$35
*
At a glance
- Drugs Tezampanel (Primary)
- Indications Thrombosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Raptor Pharmaceutical Corp
- 16 Apr 2012 New trial record